Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT06657716

Heidelberg Engineering ANTERION Software Comparison Study

This study is conducted to compare the the investigational device ANTERION with software version 1.5 against the ANTERION with software version 1.2.4 (cleared version)

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

22 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Fischer Eye Laser Center

Wilmar, Minnesota, 56201, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Normal Anterior Segment

  • Age 22 years or older
  • Able and willing to undergo the test procedures, sign informed consent, and follow instructions
  • Able to fixate
  • Eye(s) with normal anterior segment

Exclusion criteria

Normal Anterior Segment

  • Active infection or inflammation in the study eye
  • Insufficient tear film or corneal reflex
  • Physical inability to be properly positioned at the study devices or eye exam equipment
  • Rigid contact lens wear 2 weeks prior to imaging
  • Soft lenses worn within one hour prior to imaging
  • Cataract grade ≥1.5

Inclusion criteria

Abnormal Anterior Segment

  • Age 22 years or older
  • Able and willing to undergo the test procedures, sign informed consent, and follow instructions
  • Able to fixate
  • Eye(s) with abnormal anterior segment (including cataract grade ≥ 1.5)

Exclusion criteria

Abnormal Anterior Segment

  • Active infection or inflammation in the study eye
  • Insufficient tear film or corneal reflex
  • Physical inability to be properly positioned at the study devices or eye exam equipment
  • Rigid contact lens wear 2 weeks prior to imaging
  • Soft lenses worn within one hour prior to imaging

Treatment and study plan

ANTERION investigational

Device

Device: ANTERION investigational

Measurements from the investigational device ANTERION with software version 1.5 are to be compared against measurements from the ANTERION with software version 1.2.4 (cleared version)

Primary outcomes

  1. Central Cornea Thickness

    Time frame: Through study completion, an average of 1 day

    Reproducibility and repeatability of Central Cornea Thickness of ANTERION and the reference device

  2. Thinnest Point Thickness

    Time frame: Through study completion, an average of 1 day

    Reproducibility and repeatability of Thinnest Point Thickness of ANTERION and the reference device

  3. Lens Thickness

    Time frame: Through study completion, an average of 1 day

    Reproducibility and repeatability of Lens Thickness of ANTERION and the reference device

  4. Anterior Chamber Depth

    Time frame: Through study completion, an average of 1 day

    Reproducibility and repeatability of Anterior Chamber Depth of ANTERION and the reference device

  5. Axial Length

    Time frame: Through study completion, an average of 1 day

    Reproducibility and repeatability of Axial Length of ANTERION and the reference device

Secondary outcomes

  1. Adverse Events Rate

    Time frame: Through study completion, an average of 1 day

    Adverse events found during the clinical study

Sponsors and collaborators

Lead sponsor

Heidelberg Engineering GmbH

Industry

Registry information

Official study title

The Heidelberg Engineering ANTERION Software Comparison Precision and Agreement Study

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Oct 24, 2024
Registry last updated
Dec 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.